Correlation Between Inhibrx and InMed Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Inhibrx and InMed Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Inhibrx and InMed Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Inhibrx and InMed Pharmaceuticals, you can compare the effects of market volatilities on Inhibrx and InMed Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Inhibrx with a short position of InMed Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Inhibrx and InMed Pharmaceuticals.
Diversification Opportunities for Inhibrx and InMed Pharmaceuticals
0.03 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Inhibrx and InMed is 0.03. Overlapping area represents the amount of risk that can be diversified away by holding Inhibrx and InMed Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on InMed Pharmaceuticals and Inhibrx is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Inhibrx are associated (or correlated) with InMed Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of InMed Pharmaceuticals has no effect on the direction of Inhibrx i.e., Inhibrx and InMed Pharmaceuticals go up and down completely randomly.
Pair Corralation between Inhibrx and InMed Pharmaceuticals
Given the investment horizon of 90 days Inhibrx is expected to generate 0.57 times more return on investment than InMed Pharmaceuticals. However, Inhibrx is 1.76 times less risky than InMed Pharmaceuticals. It trades about -0.03 of its potential returns per unit of risk. InMed Pharmaceuticals is currently generating about -0.13 per unit of risk. If you would invest 1,580 in Inhibrx on September 2, 2024 and sell it today you would lose (54.00) from holding Inhibrx or give up 3.42% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Inhibrx vs. InMed Pharmaceuticals
Performance |
| Timeline |
| Inhibrx |
| InMed Pharmaceuticals |
Inhibrx and InMed Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Inhibrx and InMed Pharmaceuticals
The main advantage of trading using opposite Inhibrx and InMed Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Inhibrx position performs unexpectedly, InMed Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in InMed Pharmaceuticals will offset losses from the drop in InMed Pharmaceuticals' long position.| Inhibrx vs. Crinetics Pharmaceuticals | Inhibrx vs. Merus BV | Inhibrx vs. Lyell Immunopharma | Inhibrx vs. Kronos Bio |
| InMed Pharmaceuticals vs. Tff Pharmaceuticals | InMed Pharmaceuticals vs. Eliem Therapeutics | InMed Pharmaceuticals vs. Inhibrx | InMed Pharmaceuticals vs. Enliven Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.
Other Complementary Tools
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |